✦ LIBER ✦

The mechanism of chemoresistance against tyrosine kinase inhibitors in malignant glioma

✍ Scribed by Nakada, Mitsutoshi; Kita, Daisuke; Watanabe, Takuya; Hayashi, Yutaka; Hamada, Jun-ichiro

Book ID: 121578405
Publisher: Springer Japan
Year: 2014
Tongue: English
Weight: 386 KB
Volume: 31
Category: Article
ISSN: 1433-7398
DOI: 10.1007/s10014-013-0174-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of Chemoresistance to Alkylat

Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma

✍ Sarkaria, J. N.; Kitange, G. J.; James, C. D.; Plummer, R.; Calvert, H.; Weller, 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 666 KB

641 Endogenous Inhibitors of Tyrosine Ki

641 Endogenous Inhibitors of Tyrosine Kinase Receptors –a Therapeutic Role for Soluble LRIG1 in Malignant Glioma?

✍ K. Tiemann; A. Bernard; F. Fack; M. Johansson; H. Hedman; S.P. Niclou 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

596 POSTER The topoisomerase I inhibitor

596 POSTER The topoisomerase I inhibitor gimatecan exhibits synergistic activity with temozolomide and tyrosine kinase inhibitors in malignant glioma xenografts

✍ B. Geoerger; N. Hamelin; P. Rodier; P. Opolon; R. Versace; G. Vassal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Mechanisms of proteasome inhibitor-induc

Mechanisms of proteasome inhibitor-induced cytotoxicity in malignant glioma

✍ Vlachostergios, Panagiotis J.; Voutsadakis, Ioannis A.; Papandreou, Christos N. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 280 KB

Activity of tyrosine kinase inhibitors a

Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies

✍ Quintás-Cardama, A; Tong, W; Manshouri, T; Vega, F; Lennon, P A; Cools, J; Gilli 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 297 KB

Predicting chemoresistance in human mali

Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses

✍ Michael Weller; Johannes Rieger; Cornelia Grimmel; Erwin G. Van Meir; Nicolas De 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 82 KB 👁 2 views

Less than 30% of malignant gliomas respond to adjuvant chemotherapy. Here, we asked whether alterations in the p53 and RB pathways and the expression of six BCL-2 family proteins predicted acute cytotoxicity and clonogenic cell death induced by BCNU, vincristine, cytarabine, teniposide, doxorubicin,